Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico.
Basto-Abreu A, Carnalla M, Torres-Ibarra L, Romero-Martínez M, Martínez-Barnetche J, López-Martínez I, Aparicio-Antonio R, Shamah-Levy T, Alpuche-Aranda C, Rivera JA, Barrientos-Gutierrez T; ENSANUT-COVID collaborators.
Basto-Abreu A, et al.
Nat Commun. 2022 Feb 1;13(1):589. doi: 10.1038/s41467-022-28232-9.
Nat Commun. 2022.
PMID: 35105873
Free PMC article.